Evidence map›Paper›PMID 25882841›Full record

ArticleThe Journal of biological chemistry2015

Target of Rapamycin Complex 2 Regulates Actin Polarization and Endocytosis via Multiple Pathways.

Delphine Rispal, Sandra Eltschinger, Michael Stahl, Stefania Vaga, Bernd Bodenmiller, Yann Abraham, Ireos Filipuzzi, N Rao Movva, Ruedi Aebersold, Stephen B Helliwell and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 94 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Amino acid metabolism reprogramming: shedding new light on T cell anti-tumor immunity.Journal of experimental & clinical cancer research : CR · 2023
    Review
  9. Article
  10. Review
  11. The TOR complex controls ATP levels to regulate actin cytoskeleton dynamics inProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Plasma Membrane MCC/Eisosome Domains Promote Stress Resistance in Fungi.Microbiology and molecular biology reviews : MMBR · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Delphine RispalFrom the Department of Molecular Biology and Institute of Genetics and Genomics of Geneva (iGE3), University of Geneva, 1211 Geneva.
Sandra EltschingerFrom the Department of Molecular Biology and Institute of Genetics and Genomics of Geneva (iGE3), University of Geneva, 1211 Geneva.
Michael StahlFrom the Department of Molecular Biology and Institute of Genetics and Genomics of Geneva (iGE3), University of Geneva, 1211 Geneva.
Stefania Vagathe Department of Biology, Institute of Molecular Systems Biology, ETH Zürich, 8093 Zürich.
Bernd Bodenmillerthe Institute of Molecular Life Sciences, University of Zürich, 8057 Zürich.
Yann Abrahamthe Novartis Institutes for Biomedical Research, Novartis Campus, 4056 Basel.
Ireos Filipuzzithe Novartis Institutes for Biomedical Research, Novartis Campus, 4056 Basel.
N Rao Movvathe Novartis Institutes for Biomedical Research, Novartis Campus, 4056 Basel.
Ruedi Aebersoldthe Department of Biology, Institute of Molecular Systems Biology, ETH Zürich, 8093 Zürich, the Faculty of Science, University of Zürich, 8057 Zürich, and.
Stephen B Helliwellthe Novartis Institutes for Biomedical Research, Novartis Campus, 4056 Basel, stephen.helliwell@novartis.com.
Robbie LoewithFrom the Department of Molecular Biology and Institute of Genetics and Genomics of Geneva (iGE3), University of Geneva, 1211 Geneva, the National Centre for Competence in Research Chemical Biology, 1211 Geneva, Switzerland robbie.loewith@unige.ch.
University of Geneva · CHNovartis Institutes for BioMedical ResearchNovartis (Switzerland) · CHUniversity of Zurich · CHETH Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Target of rapamycin is a Ser/Thr kinase that operates in two conserved multiprotein complexes, TORC1 and TORC2. Unlike TORC1, TORC2 is insensitive to rapamycin, and its functional characterization is less advanced. Previous genetic studies demonstrated that TORC2 depletion leads to loss of actin polarization and loss of endocytosis. To determine how TORC2 regulates these readouts, we engineered a yeast strain in which TORC2 can be specifically and acutely inhibited by the imidazoquinoline NVP-BHS345. Kinetic analyses following inhibition of TORC2, supported with quantitative phosphoproteomics, revealed that TORC2 regulates these readouts via distinct pathways as follows: rapidly through direct protein phosphorylation cascades and slowly through indirect changes in the tensile properties of the plasma membrane. The rapid signaling events are mediated in large part through the phospholipid flippase kinases Fpk1 and Fpk2, whereas the slow signaling pathway involves increased plasma membrane tension resulting from a gradual depletion of sphingolipids. Additional hits in our phosphoproteomic screens highlight the intricate control TORC2 exerts over diverse aspects of eukaryote cell physiology.

Indexed as

EndocytosisActinsFungal ProteinsMechanistic Target of Rapamycin Complex 2Multiprotein ComplexesPhosphorylationPrincipal Component AnalysisProtein KinasesProteomicsSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSignal TransductionTOR Serine-Threonine KinasesActinsFpk1 protein, S cerevisiaeFpk2 protein, S cerevisiaeFungal ProteinsMechanistic Target of Rapamycin Complex 2Multiprotein ComplexesProtein KinasesSaccharomyces cerevisiae ProteinsTOR Serine-Threonine Kinasescell signalinglipid signalingphosphoproteomeplasma membraneprotein kinasetarget of rapamycin complex 2, Ypk1, sphingolipids, actin polarization, endocytosis, flippase kinasetarget of rapamycin (TOR)

Identifiers

PMID25882841
PMCPMC4463442
OpenAlexW2031475382

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.